Influence of matching for HLA-DR antigens on skin graft survival. 1979

M Jonker, and J Hoogeboom, and A van Leeuwen, and C T Koch, and D Blussé van Oud Alblas, and J J van Rood

HLA-DR typing results of 47 skin transplant donor-recipient pairs were analysed. HLA-A, B, and C typing and mixed lymphocyte culture (MLC) testing was also included in this study. Skin transplants exchanged between HLA-A-, B-, and DR-identical, MLC-negative donor-recipient pairs had the longest graft survival (mean survival time, 17 days), whereas skin grafts exchanged between completely nonidentical donor-recipient combinations had the shortest survival (mean survival time, 10 days). Because of the correlation between identity for the DR antigens and the low or nonreactivity in the MLC test, identity for DR will predict a better skin graft survival than nonidentity. It was concluded that the best match between donor and recipient of a graft, using only serological techniques, is one where there is identity for HLA-A, B, and DR.

UI MeSH Term Description Entries
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D016038 Skin Transplantation The grafting of skin in humans or animals from one site to another to replace a lost portion of the body surface skin. Dermatoplasty,Grafting, Skin,Transplantation, Skin,Dermatoplasties,Graftings, Skin,Skin Grafting,Skin Graftings,Skin Transplantations,Transplantations, Skin

Related Publications

M Jonker, and J Hoogeboom, and A van Leeuwen, and C T Koch, and D Blussé van Oud Alblas, and J J van Rood
January 1981, Scandinavian journal of urology and nephrology. Supplementum,
M Jonker, and J Hoogeboom, and A van Leeuwen, and C T Koch, and D Blussé van Oud Alblas, and J J van Rood
January 1975, Scandinavian journal of urology and nephrology,
M Jonker, and J Hoogeboom, and A van Leeuwen, and C T Koch, and D Blussé van Oud Alblas, and J J van Rood
January 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
M Jonker, and J Hoogeboom, and A van Leeuwen, and C T Koch, and D Blussé van Oud Alblas, and J J van Rood
August 1990, Transplantation proceedings,
M Jonker, and J Hoogeboom, and A van Leeuwen, and C T Koch, and D Blussé van Oud Alblas, and J J van Rood
April 1979, Transplantation,
M Jonker, and J Hoogeboom, and A van Leeuwen, and C T Koch, and D Blussé van Oud Alblas, and J J van Rood
December 1992, Transplantation proceedings,
M Jonker, and J Hoogeboom, and A van Leeuwen, and C T Koch, and D Blussé van Oud Alblas, and J J van Rood
January 1984, Annals of clinical and laboratory science,
M Jonker, and J Hoogeboom, and A van Leeuwen, and C T Koch, and D Blussé van Oud Alblas, and J J van Rood
September 1992, Transplantation,
M Jonker, and J Hoogeboom, and A van Leeuwen, and C T Koch, and D Blussé van Oud Alblas, and J J van Rood
September 1999, Transplantation proceedings,
M Jonker, and J Hoogeboom, and A van Leeuwen, and C T Koch, and D Blussé van Oud Alblas, and J J van Rood
August 1981, Tissue antigens,
Copied contents to your clipboard!